Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1186/s12967-017-1262-0 https://repositorio.unifesp.br/handle/11600/53434 |
Resumo: | Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics. |
id |
UFSP_94432ab3dcb0e9fe19f3db76a7f7ebcc |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br:11600/53434 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Dias, Lucinara DaddaCasali, Karina Rabello [UNIFESP]Ghem, Carineda Silva, Melissa KristocheckSausen, GrasielePalma, Patricia BoniniCovas, Dimas TadeuKalil, Renato A. K.Schaan, Beatriz D.Nardi, Nance BeyerMarkoski, Melissa Medeiros2020-06-26T16:30:14Z2020-06-26T16:30:14Z2017http://dx.doi.org/10.1186/s12967-017-1262-0Journal Of Translational Medicine. London, v. 15, p. -, 2017.1479-5876https://repositorio.unifesp.br/handle/11600/53434WOS000406324500001.pdf10.1186/s12967-017-1262-0WOS:000406324500001Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.CNPq-Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Programa de Cooperacao Academico (Procad)FAPERGS-Fundacao de Amparo a Pesquisa do Estado do Rio Grande do SulFundacao Univ Cardiol, Inst Cardiol, Programa Posgrad Ciencias Saude Cardiol, Ave Princesa Isabel,370,3 Andar, BR-90620001 Porto Alegre, RS, BrazilUniv Fed Sao Paulo, Sao Jose Dos Campos, SP, BrazilHosp Clin Porto Alegre, Serv Patol Clin, Porto Alegre, RS, BrazilUniv Sao Paulo, Fac Med Ribeirao Preto, Lab Citometria Fluxo, Ctr Reg Hemoterapia,Hosp Clin, Sao Paulo, SP, BrazilUniv Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, BrazilUniv Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, BrazilUniv Luterana Brasil, Lab Celulas Tronco & Engn Tecidos, Canoas, RS, BrazilUniv Fed Sao Paulo, Sao Jose Dos Campos, SP, BrazilCNPqCAPESFAPERGSWeb of Science-engBiomed Central LtdJournal Of Translational MedicineMSC establishmentStem cells cultureCell therapyValvular heart diseaseIschemic heart diseaseMesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kineticsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleLondon15info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000406324500001.pdfapplication/pdf1709723${dspace.ui.url}/bitstream/11600/53434/1/WOS000406324500001.pdf62ae4804ebd8c9b8772ad056e183820eMD51open accessTEXTWOS000406324500001.pdf.txtWOS000406324500001.pdf.txtExtracted texttext/plain43300${dspace.ui.url}/bitstream/11600/53434/8/WOS000406324500001.pdf.txt9a2dab84655495711db5e3b6770b51a7MD58open accessTHUMBNAILWOS000406324500001.pdf.jpgWOS000406324500001.pdf.jpgIM Thumbnailimage/jpeg6931${dspace.ui.url}/bitstream/11600/53434/10/WOS000406324500001.pdf.jpg1d38122c2fd218b518f775d366997120MD510open access11600/534342023-06-05 19:09:18.763open accessoai:repositorio.unifesp.br:11600/53434Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-06-05T22:09:18Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.en.fl_str_mv |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
spellingShingle |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics Dias, Lucinara Dadda MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
title_short |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_full |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_fullStr |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_full_unstemmed |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_sort |
Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
author |
Dias, Lucinara Dadda |
author_facet |
Dias, Lucinara Dadda Casali, Karina Rabello [UNIFESP] Ghem, Carine da Silva, Melissa Kristocheck Sausen, Grasiele Palma, Patricia Bonini Covas, Dimas Tadeu Kalil, Renato A. K. Schaan, Beatriz D. Nardi, Nance Beyer Markoski, Melissa Medeiros |
author_role |
author |
author2 |
Casali, Karina Rabello [UNIFESP] Ghem, Carine da Silva, Melissa Kristocheck Sausen, Grasiele Palma, Patricia Bonini Covas, Dimas Tadeu Kalil, Renato A. K. Schaan, Beatriz D. Nardi, Nance Beyer Markoski, Melissa Medeiros |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Dias, Lucinara Dadda Casali, Karina Rabello [UNIFESP] Ghem, Carine da Silva, Melissa Kristocheck Sausen, Grasiele Palma, Patricia Bonini Covas, Dimas Tadeu Kalil, Renato A. K. Schaan, Beatriz D. Nardi, Nance Beyer Markoski, Melissa Medeiros |
dc.subject.eng.fl_str_mv |
MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
topic |
MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
description |
Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics. |
publishDate |
2017 |
dc.date.issued.fl_str_mv |
2017 |
dc.date.accessioned.fl_str_mv |
2020-06-26T16:30:14Z |
dc.date.available.fl_str_mv |
2020-06-26T16:30:14Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.].fl_str_mv |
http://dx.doi.org/10.1186/s12967-017-1262-0 |
dc.identifier.citation.fl_str_mv |
Journal Of Translational Medicine. London, v. 15, p. -, 2017. |
dc.identifier.uri.fl_str_mv |
https://repositorio.unifesp.br/handle/11600/53434 |
dc.identifier.issn.none.fl_str_mv |
1479-5876 |
dc.identifier.file.none.fl_str_mv |
WOS000406324500001.pdf |
dc.identifier.doi.none.fl_str_mv |
10.1186/s12967-017-1262-0 |
dc.identifier.wos.none.fl_str_mv |
WOS:000406324500001 |
url |
http://dx.doi.org/10.1186/s12967-017-1262-0 https://repositorio.unifesp.br/handle/11600/53434 |
identifier_str_mv |
Journal Of Translational Medicine. London, v. 15, p. -, 2017. 1479-5876 WOS000406324500001.pdf 10.1186/s12967-017-1262-0 WOS:000406324500001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
Journal Of Translational Medicine |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
- |
dc.coverage.none.fl_str_mv |
London |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
bitstream.url.fl_str_mv |
${dspace.ui.url}/bitstream/11600/53434/1/WOS000406324500001.pdf ${dspace.ui.url}/bitstream/11600/53434/8/WOS000406324500001.pdf.txt ${dspace.ui.url}/bitstream/11600/53434/10/WOS000406324500001.pdf.jpg |
bitstream.checksum.fl_str_mv |
62ae4804ebd8c9b8772ad056e183820e 9a2dab84655495711db5e3b6770b51a7 1d38122c2fd218b518f775d366997120 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
|
_version_ |
1802764237468073984 |